r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

MS

Mark C. Schneyer

Insider · EVP, Chief Financial Officer · ACAD

Mark C. Schneyer files insider transactions with the SEC as an evp, chief financial officer of Acadia Pharmaceuticals (ACAD). We hold 6 disclosed purchases and sales filed since 25 February 2022, 2 of them in the last 90 days.

  • Files forACAD
  • Disclosed buys and sells6 in all, 2 in the last 90 days
  • Last disclosure7 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 23 February 2022 — 6 August 2026EVP, Chief Financial Officer · Acadia Pharmaceuticals (ACAD)108 Form 4 lines · source: SEC Form 4

Everything they disclosed

108 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.